Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2022-01-28 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by a shareholder. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs the reporting of such events. The content includes details of the lost share certificates and a request to trading members to refrain from trading those shares. It also includes a letter from the Registrar and Transfer Agent (RTA) confirming receipt of the information. The document is a notification about a specific event related to share certificates, not a financial report, earnings release, or management discussion. It is a regulatory announcement informing the market and exchanges about the loss of share certificates and the issuance of duplicates. This fits the category of Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit into more specific categories like share issue, director dealings, or capital updates.
2022-01-28 English
Intimation of Issue of Duplicate Shares
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges and concerns the loss of share certificates by a shareholder. It includes details about the lost certificates and requests the exchanges to inform trading members to refrain from trading these shares. The document also encloses a letter from the Registrar and Transfer Agent (RTA) confirming receipt of the information. The content is regulatory in nature, related to compliance with SEBI regulations about lost share certificates, and does not contain financial data, earnings, management discussion, or any report publication. It is an announcement of a regulatory event rather than a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-01-28 English
Dividend Updates
Notice of Dividend Amount Classification · 90% confidence The document is a letter addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements. It announces the approval by the Board of Audited Standalone Financial Results and Unaudited Consolidated Financial Results for the quarter and nine months ended 31 December 2021, along with audit and limited review reports. It also mentions a press release on financial results and an interim dividend declaration. The document is short (2157 characters) and primarily serves as an announcement of the financial results and dividend, not the full financial report itself. Therefore, it is not the full Interim/Quarterly Report (IR) or Annual Report (10-K). It is an update on capital distribution (dividend) and financial results announcement. Given the presence of dividend information and financial results announcement, the best fitting category is Notice of Dividend Amount (DIV), as the dividend declaration is a key part of the document and the financial results are summarized rather than fully presented. Confidence is high due to clear dividend declaration and financial results announcement in a short regulatory filing.
2022-01-25 English
Date of payment of dividend
Notice of Dividend Amount Classification · 90% confidence The document is a letter addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements. It announces the approval by the Board of Audited Standalone Financial Results and Unaudited Consolidated Financial Results for the quarter and nine months ended 31 December 2021, along with audit and limited review reports. It also mentions a press release on financial results and an interim dividend declaration. The document is short (2157 characters) and primarily serves as an announcement of the financial results and dividend, not the full financial report itself. Therefore, it is an announcement related to capital distribution and financial results but does not contain the full financial statements or detailed analysis. The key elements are the interim dividend announcement and financial results approval. Given the presence of dividend information and financial results announcement, the best fitting category is Notice of Dividend Amount (DIV), as the dividend details are explicitly stated and the financial results are summarized rather than fully presented. The document is not a full earnings release (ER) or interim report (IR) because it lacks detailed financial data and analysis. It is also not a report publication announcement (RPA) because it includes substantive information about dividend and results approval. Hence, the classification is DIV with high confidence.
2022-01-25 English
We would like to inform that the Board has at its meeting held today approved an interim dividend of Rs. 25/- (500 %) per equity share of Rs. 5/- fully paid up. The dividend is expected ....
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI Listing Obligations, indicating an announcement. It states that the Board has approved audited standalone financial results and unaudited consolidated financial results for the quarter and nine months ended December 31, 2021, and that these results are enclosed. It also mentions a press release on financial results and an interim dividend declaration. The document length is 2143 characters, which is relatively short and consistent with an announcement rather than the full financial report. The text does not contain detailed financial statements or substantive financial data itself but refers to the results being enclosed and available on the company's website. Therefore, this document is an announcement of financial results and dividend declaration, not the full report. According to the rules, such announcements fall under Capital/Financing Update (CAP) due to the dividend and financial results update, or possibly Earnings Release (ER) if it is primarily about quarterly results. However, since it includes dividend declaration and financial results approval, CAP is more appropriate. Confidence is high given the clear regulatory references and content.
2022-01-25 English
The presentation on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 to be made to analysts is enclosed for your records.
Investor Presentation Classification · 95% confidence The document is a presentation addressed to analysts regarding unaudited consolidated financial results for the quarter and nine months ended December 31, 2021. It includes revenue summaries and financial highlights for Q3 FY 2021-22. The document is explicitly described as a presentation to analysts, which aligns with the definition of an Investor Presentation (IP). The document length is 1970 characters, which is short but contains substantive financial data and analysis, consistent with an investor presentation rather than a brief announcement or report publication notice.
2022-01-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.